Fact CheckerSign in

NCT06155786Completed

Cognitive Effects of tDCS and tRNS in Schizophrenia

Cognitive Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Random Noise Stimulation (tRNS) in Schizophrenia: A Random, Crossover Study

Source: ClinicalTrials.gov · Last updated 18 Mar 2026

Brief summary (registry, in English)

The purpose of this study is to investigate the cognitive effects of different electrical stimulation modalities, such as transcranial direct and random-noise stimulation over the dorsolateral prefrontal cortex, in schizophrenia.

Status (registry)
Completed
Study type
Interventional
Enrollment
36 (actual)
First submitted
24 Nov 2023
Start date
1 Jan 2023
Primary completion date
1 Nov 2023
Lead sponsor
The National Brain Mapping Laboratory (NBML)
NCT number
NCT06155786

What you commit to

  • Study type: Interventional
  • Participants enrolled: 36
  • From 1 Jan 2023 to the primary completion date, 1 Nov 2023
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Presence of ferromagnetic objects in the body that are contraindicated for brain stimulation of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments)

Other illness

  • comorbid bipolar disorder and mood disorder
  • history of seizure
  • history of neurological disorder
  • history of head injury

Other

  • pregnancy
  • alcohol or substance dependence

Who the study is looking for

  • Diagnosis of schizophrenia based on Diagnostic and Statistical Manual (DSM)5
  • Being 18-50 years old (male and female)
  • If female, negative urine pregnancy test
  • feasibility for tDCS/tRNS interventions according to safety guidelines
  • stable medication regime, especially for classical neuroleptics and all central nervous system activating medications, if taken, 4-6 weeks before the experiment
  • fluency in the native language
  • right-handed
  • Required written informed consent signed by patients' guardian

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Payame Noor University, Tehran Branch
Coordinator of this site? Confirm its status
TehranIranUnknown status
Zanjan University
Coordinator of this site? Confirm its status
ZanjānIranUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.